Nikolaos G. Almyroudis

Roswell Park Comprehensive Cancer Center

Papers

1

Total Citations

4

H-Index

1

About

Nikolaos G. Almyroudis is a leading expert in infectious diseases and transplantation, with a particular focus on antimicrobial prophylaxis and infection control in surgical oncology. His work bridges the critical gap between urologic surgery and infectious disease management, especially in high-risk procedures like robot-assisted radical cystectomy (RARC). In his landmark 2025 randomized controlled trial, Almyroudis investigated whether prophylactic antibiotics reduce the rate of urinary tract infections following RARC, a question with profound implications for postoperative care and antibiotic stewardship. This study, which has already garnered 4 citations shortly after publication, addresses the urgent need to balance infection prevention with the growing threat of antimicrobial resistance. Beyond this work, Almyroudis has contributed extensively to the understanding of fungal infections in immunocompromised patients and the optimization of perioperative antimicrobial regimens. His research is characterized by rigorous methodology and a patient-centered approach, aiming to reduce morbidity while minimizing unnecessary antibiotic exposure. For students and researchers, Almyroudis exemplifies how targeted clinical trials can directly inform surgical practice and improve outcomes in vulnerable populations.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Do Prophylactic Antibiotics Decrease the Rate of Urinary Tract Infections After Robot-Assisted Radical Cystectomy? A Randomized Controlled Trial
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Roswell Park Comprehensive Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago